Verrica Pharmaceuticals
(NASDAQ) VRCA
Verrica Pharmaceuticals Financials at a Glance
Market Cap
$75.24M
Revenue (TTM)
$35.58M
Net Income (TTM)
$17.89M
EPS (TTM)
$-1.61
P/E Ratio
-2.73
Dividend
$0.00
Beta (Volatility)
0.86 (Low)
Dividend
$0.00
Beta (Volatility)
0.86 (Low)
Price
$4.75
Volume
2,281
Open
$4.53
Price
$4.75
Volume
2,281
Open
$4.53
Previous Close
$4.75
Daily Range
$4.50 - $4.82
52-Week Range
$3.28 - $9.82
Dividend
$0.00
Beta (Volatility)
0.86 (Low)
Price
$4.75
Volume
2,281
Open
$4.53
Previous Close
$4.75
Daily Range
$4.50 - $4.82
52-Week Range
$3.28 - $9.82
VRCA News
VRCA: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Verrica Pharmaceuticals
Industry
Pharmaceuticals
Sector
Health CareEmployees
76
CEO
Jayson M. Rieger, PhD, MBA
Website
www.verrica.comHeadquarters
West Chester, PA 19380, US
VRCA Financials
Key Financial Metrics (TTM)
Gross Margin
91%
Operating Margin
-34%
Net Income Margin
-50%
Return on Equity
-240%
Return on Capital
-39%
Return on Assets
-38%
Earnings Yield
-36.63%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$75.24M
Shares Outstanding
17.18M
Volume
2.28K
Short Interest
0.00%
Avg. Volume
150.91K
Financials (TTM)
Gross Profit
$32.14M
Operating Income
$11.94M
EBITDA
$11.16M
Operating Cash Flow
$17.63M
Capital Expenditure
$0.00
Free Cash Flow
$17.63M
Cash & ST Invst.
$30.15M
Total Debt
$1.63M
Verrica Pharmaceuticals Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$5.09M
+1380.2%
Gross Profit
$3.69M
+1413.5%
Gross Margin
72.49%
N/A
Market Cap
$75.24M
N/A
Market Cap/Employee
$1.06M
N/A
Employees
71
N/A
Net Income
$8.07M
+50.2%
EBITDA
$8.37M
+38.5%
Quarterly Fundamentals
Net Cash
$28.52M
+7211.8%
Accounts Receivable
$5.40M
+6909.1%
Inventory
$2.24M
-9.2%
Long Term Debt
$1.77M
-94.5%
Short Term Debt
$746.00K
-94.5%
Return on Assets
-37.95%
N/A
Return on Invested Capital
-38.90%
N/A
Free Cash Flow
$4.59M
+71.4%
Operating Cash Flow
$4.59M
+71.4%